Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials
Clotet, Bonaventura, Dr, Bellos, Nicholas, MD, Molina, Jean-Michel, MD, Cooper, David, MD, Goffard, Jean-Christophe, MD, Lazzarin, Adriano, MD, Wöhrmann, Andrej, MD, Katlama, Christine, Prof, Wilkin, Timothy, MD, Haubrich, Richard, Prof, Cohen, Calvin, MD, Farthing, Charles, MD, Jayaweera, Dushyantha, MD, Markowitz, Martin, MD, Ruane, Peter, MD, Spinosa-Guzman, Sabrina, MD, Lefebvre, Eric, MD
Published in The Lancet (British edition) (07.04.2007)
Published in The Lancet (British edition) (07.04.2007)
Get full text
Journal Article